70
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Introduction autoantibodies—the smoke and the fire

&
Pages 1-2 | Received 11 Sep 2004, Accepted 15 Sep 2004, Published online: 07 Jul 2009

References

  • Hargraves MM, Richmond H, Morton R. Presentation of two bone marrow elements: the 'tart' cell and the 'LE' cell. Proc Staff Meet Mayo Clin 1948;23–25.
  • Hayakawa I, Hasegawa M, Takehara K, Sato S. Anti-DNA topoisomerase IIalpha autoantibodies in localized sclero-derma. Arthritis Rheum 2004;50:227–232.
  • Ilic T, Curic S, Vodopivec S, Mitic I, Durdevic-Mirkovic T, Sakac V. Lenert Anti-U1RNP antibodies and lupus nephritis. Med Pregl 2000;53: 589–594.
  • Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, Harley JB. Development of auto-antibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003;349:1499–1500.
  • Orbach H, Gilburd B, Brickman CM, Gerli R, Shoenfeld Y. Anti-cyclic citrullinated peptide antibodies as a diagnostic test for rheumatoid arthritis and predictor of an erosive disease. IMAJ 2002;4:892–893.
  • Markus MJ Nielen, Dirkjan van Schaardenburg, Henk W Reesink, Rob J Van de Stadt, Irene E van der Horst-Bruinsma, Margret HMT de Koning, Moud R Habibuw, Jan P Vandenbroucke. Specific autoantibodies precede the symp-toms of rheumatoid arthritis: A study of serial measurements in blood donors. Arthritis Rheum 2004;50:380–386.
  • Van Gaalen FA, Linn-Rasker SP, van Venrooij WJ, de Jong BA, Breedveld FC, Verweij CL, Toes RE, Huizinga TW. Autoantibodies to cyclic citrulinated peptides predict pro-gression to rheumatoid arthritis in patients with undiffer-entiated arthritis; a prospective cohort study. Arthritis Rheum 2004;50:709–715.
  • Dang H, Takei M, Isenberg DA, Shoenfeld Y, Bakimer R, Rauch J, Talal N. Expression of an interspecies idiotype in sera of SLE patients and their first degree relatives. Clin Exp Immunol 1988;71:445–450.
  • Mendlovic S, Segal R, Shoenfeld Y, Mozes E. Anti-DNA idiotype and anti idiotype specific T cell responses in patients with SLE and their first degree relatives. Clin Exp Immunol 1990;82:504–508.
  • Mattalia A, Quaranta S, Leung PSC, Bauducci M, Van de Water J, Calvo PL, Danielle F, Rizzetto M, Ansari A, Coppel RL, Rosina F, Gershwin M. Characterization of antimito-chondrial antibodies in healthy adults. Hepatology 1998;27:656–661.
  • Poupon RE, Lindor KD, Pares A, Chazouilleres O, Poupon R, Heathcote EJ. Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis. J Hepatol 2003;39:12–16.
  • Blank M, Cohen J, Toder V, Shoenfeld Y. Induction of anti-phospholipid syndrome by passive transfer of anti-cardiolipin antibodies. Proc Natl Acad Sci 1991;88:3069–3073.
  • DeGiorgio LA, Konstantinov KN, Lee SC, Hardin JA, Volpe BT, Diamond B. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 2001;7:1189–1193.
  • Guo H, Leung JCK, Chan LYY, Chan TM, Lai KN. The pathogenetic role of immunoglobulin G from patients with systemic lupus erythematosus in the development of lupus pleuritis. Rheumatology 2004;43:286–293.
  • Sherer Y, Gorstein A, Shoenfeld Y, Fritzler—Autoantibodies explosion in systemic lupus erythematosus- more than 100 different antibodies in lupus patients. Sem Arth & R 2004;34:501–537.
  • Tincani A, Franceschini F, Spunghi M, Panzeri P, Balestrieri G, Meroni PL. Immunological abnormalities in the anti-phospholipid syndrome. In: Asherson RA, Cervera R, Piette JC, Shoenfeld J, editors. The antiphospholipid syndrome II. Amsterdam: Elsevier; 2002. p 271–284.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.